The validity of male patients' self reports regarding prostate cancer screening
The validity of male patients' self reports regarding prostate cancer screening
复制标题
DOI：
10.1006/pmed.1998.0430
复制
发表时间：
1999-03-01
影响因子：
5.1
通讯作者：
Bedell, AW
中科院分区：
文献类型：
--
作者：
Jordan, TR;Price, JH;Bedell, AW
背景尽管前列腺癌筛查率很高，但男性患者自我报告的筛查准确性尚未得到调查。本研究评估患者自我报告的前列腺筛查与病历的一致性。焦点小组进行，以获得男性患者的前列腺癌筛查和显着的术语的看法。男性样本（n = 276），40岁或以上，完成了15项问卷。然后将患者的PSA和DRE筛查自我报告与病历进行比较。结果显示，患者的DRE和PSA的自我报告与病历不一致的时间分别为32%和29%。患者自我报告DRE和PSA的敏感性分别为82%和74%。患者自我报告的DRE和PSA特异性分别为56%和65%。五分之一的患者报告说，他们不确定医生如何检查男性的前列腺。只有39%的患者知道前列腺可以通过血液检查。患者自述与病历比较差异有统计学意义。这些结果应该引起初级保健医生和那些评估前列腺癌筛查项目有效性的人的关注。（C）1999年美国健康基金会和学术出版社。
Background. Despite the high rate of prostate cancer screening, the accuracy of male patients' self-reports of screening has not been investigated. This study assessed the concordance between patients' self-reports of prostate screening and the medical record.Methods. Focus groups were conducted to obtain male patients' perceptions of prostate cancer screening and salient terminology. A sample of males (n = 276), 40 years of age or older, completed a 15-item questionnaire. Patients' self-reports of PSA and DRE screening were then compared with medical records.Results. Results showed that patients' self-reports of DRE and PSA were discordant with the medical record 32 and 29% of the time, respectively. Sensitivity of patients' self-reports for DRE and PSA was 82 and 74%, respectively. Specificity of patients' self-reports for DRE and PSA was 56 and 65%, respectively. One in five patients reported that they were not sure how a doctor checks a man's prostate gland. Only 39% of patients knew that the prostate gland can be checked by a blood test.Conclusions. There were significant differences between patients' self-reports and the medical record. The results should be of concern to primary care practitioners and to those who evaluate the efficacy of prostate cancer screening programs. (C)1999 American Health Foundation and Academic Press.